Celltrion said Friday it had completed the acquisition of Eli Lilly’s plant in Branchburg, New Jersey, closing the deal about ...

Eli Lilly and Company rated Buy: incretin/obesity growth, ZEPBOUND & orforglipron access strategy, pipeline deals, ...

Alnylam Pharmaceuticals has announced a $250 million investment to expand its manufacturing facility in Massachusetts. The ...

Eli Lilly and Company (Lilly) plans to construct an active pharmaceutical ingredient (API) manufacturing facility, totaling around 1 million square feet, in Harris County, Texas. According to news ...

Indiana Attorney General Todd Rokita sues Eli Lilly, accusing them of inflating insulin prices by over 1000% despite low manufacturing costs.

Picking a date for a press conference in Puerto Rico in the middle of hurricane season can be risky business. But, these days, there’s no stopping Eli Lilly’s whirlwind of manufacturing investment ...

Indiana Attorney General Todd Rokita is taking legal action against Eli Lilly and Company to lower insulin prices and improve ...

In an announcement Monday, Nov. 3, the Indianapolis-based pharmaceutical company said the new site will manufacture its weight-loss pill, orforglipron, and other oral medicines. Lilly expects to ...

Rokita says Eli Lilly was part of a scheme that inflated insulin prices over the past decade by more than 1000%, despite low ...

Nimbus will apply its computational chemistry and structure-based drug design to a discovery programme in obesity treatment.

HUNTSVILLE, Ala. (WHNT) — Pharmaceutical giant Eli Lilly announced on Tuesday it plans to invest more than $6 billion in a new manufacturing plant in Huntsville. Company officials said the site will ...

Indiana Attorney General Todd Rokita on Monday announced a new lawsuit against Indianapolis-based drug maker Eli Lilly and Co. The attorney general contends this suit, as well as previous litigation ...